demonstration
human
leukocyte
degranulation
induced
sera
homozygotes
heterozygotes
cystic
fibrosis
ability
epsilon
amino
caproic
acid
eaca
treated
normal
serum
cystic
fibrosis
cf
affected
carrier
sera
promote
release
lysosomal
enzymes
sensitized
human
polymorphonuclear
leukocytes
pmn
assessed
measurement
beta
glucuronidase
myeloperoxidase
activity
exposure
cells
various
test
sera
study
initiated
extend
analogies
preciliary
dyskinesia
factor
pre
cdf
separated
cell
free
media
cultures
derived
cf
homozygous
heterozygous
individuals
c
anaphylatoxin
extent
lysosomal
degranulation
human
pmn
exposed
fresh
untreated
sera
five
controls
seven
cf
homozygotes
eight
heterozygotes
expressed
amount
beta
glucuronidase
releases
control
sera
cf
affected
sera
heterozygous
sera
difference
cf
homozygotes
control
subjects
significant
p
less
difference
cf
affected
carrier
individuals
less
p
less
control
subjects
carriers
less
p
less
beta
glucuronidase
however
differences
control
subjects
cf
heterozygous
individuals
significant
treatment
sera
eaca
gave
values
beta
glucuronidase
myeloperoxidase
release
slightly
reduced
compared
obtained
fresh
untreated
samples
eaca
apparently
reduces
activity
beta
glucuronidase
released
pmn
amicon
filtration
studies
serum
samples
demonstrated
degranulating
ability
presence
cilicary
dyskinesia
assessed
rabbit
tracheal
bioassay
always
associated
therefore
relationship
pre
cdf
degranulator
activity
native
cf
affected
carrier
sera
unclear
part
limitations
inherent
test
systems
employed
